Skip to content

A study on natural therapeutic approaches in glaucoma therapy

A study on natural therapeutic approaches in glaucoma therapy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001055
Enrollment
Unknown
Registered
2010-10-01
Start date
2010-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Group A:0.004% travoprost, once a day
exercise (1, 3,5/2, 4, 6 exercise program: the first number is the kilimeters of requesting to run
the second number is how many times requesting to exercise per week
the third number is the target heart rate 150/160-ages)
Group B:the first number is the kilimeters of requesting

Sponsors

Beijing Tong Ren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Male and female aged 18 to 65 years old; 2.Able and willing to provide signed informed consent; 3. Meet the diagnostic criteria of Primary Open Angle Glaucoma; 4. Do not use the systemic or local drug of vasodilators or improvement of microcirculation nearly one month.

Exclusion criteria

Exclusion criteria: 1. The action is difficult, or have severe cervical and lumbar disease who can not exercise; 2. Usually adhere to the exercise; 3. Advanced Glaucomatous Field Defects; 4. With severe conjunctival diseases, cornea diseases, scleral diseases, the lens disease except for the early cataract , uveal diseases, retinal diseases and other eye diseases; 5. Pregnant or lactating women; 6. Associated with primary disease of cardiovascular, cerebrovascular, liver and kidney, hematopoietic system or other serious mental illness.

Design outcomes

Primary

MeasureTime frame
Intraocular pressure;

Secondary

MeasureTime frame
heat shock protein 27and 70;Optical coherence tomography;visual acuity;Vision field;

Countries

China

Contacts

Public ContactNingli Wang
wningli@vip.163.com+86 10 58269968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026